Insulin Glargine Injection, Solution
Product Images NDC 72572-422

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 27 technical images submitted to the FDA as part of the official labeling for Insulin Glargine (NDC 72572-422). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Site Of Injection On Body (Image 01)

FDA Label Image

Image-02r (Image 02r)

Image-02r (Image 02r)
This text appears to describe a cartridge pen for injections. It mentions expiration dates, doses, and a window selector. The package may include a needle for the pen.*
FDA Label Image

Image-03r (Image 03r)

FDA Label Image

Image-04 (Image 04)

FDA Label Image

Image-04a (Image 04a)

FDA Label Image

Image-05a (Image 05a)

FDA Label Image

Image-06 (Image 06)

FDA Label Image

Image-07 (Image 07)

FDA Label Image

Image-08 (Image 08)

FDA Label Image

Image-09 (Image 09)

FDA Label Image

Image-10 (Image 10)

FDA Label Image

Image-11 (Image 11)

FDA Label Image

Image-12 (Image 12)

FDA Label Image

Image-13r (Image 13r)

FDA Label Image

Image-14r (Image 14r)

FDA Label Image

Image-15 (Image 15)

FDA Label Image

Image-16 (Image 16)

FDA Label Image

Image-17 (Image 17)

FDA Label Image

Image-18 (Image 18)

FDA Label Image

Image-19 (Image 19)

FDA Label Image

Image-20 (Image 20)

FDA Label Image

Image-21 (Image 21)

FDA Label Image

Image-22 (Image 22)

FDA Label Image

Image-23 (Image 23)

FDA Label Image

Image-24 (Image 24)

FDA Label Image

Image-25 (Image 25)

FDA Label Image

Image-28 (Image 28)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.